ArticleBreast cancer research : BCR2015

Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.

Ahrum Min et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.